FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis.

MLA

Sakuma, S., et al. “FK506 Is Superior to Methotrexate in Therapeutic Effects on Advanced Stage of Rat Adjuvant-Induced Arthritis.” Inflammation Research, vol. 50, no. 10, Oct. 2001, pp. 509–14. EBSCOhost, https://doi.org/10.1007/PL00000227.

APA

Sakuma, S., Nishigaki, F., Magari, K., Ogawa, T., Miyata, S., Ohkubo, Y., & Goto, T. (2001). FK506 is superior to methotrexate in therapeutic effects on advanced stage of rat adjuvant-induced arthritis. Inflammation Research, 50(10), 509–514. https://doi.org/10.1007/PL00000227

Chicago

Sakuma, S., F. Nishigaki, K. Magari, T. Ogawa, S. Miyata, Y. Ohkubo, and T. Goto. 2001. “FK506 Is Superior to Methotrexate in Therapeutic Effects on Advanced Stage of Rat Adjuvant-Induced Arthritis.” Inflammation Research 50 (10): 509–14. doi:10.1007/PL00000227.